Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 50,302 | reported | 02 Mar 2026 | tx 128+204,346−78,658 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Mar 2026 | SALE | Ultragenyx Pharmaceutical Inc. | 1,632 | 22.80 USD | |
| 02 Mar 2026 | TAX_WITHHOLDING | Ultragenyx Pharmaceutical Inc. | 148 | 23.39 USD | |
| 29 Dec 2025 | SALE | Ultragenyx Pharmaceutical Inc. | 85 | 34.38 USD | |
| 18 Sept 2025 | SALE | Ultragenyx Pharmaceutical Inc. | 64 | 29.17 USD | |
| 05 Sept 2025 | SALE | Ultragenyx Pharmaceutical Inc. | 84 | 31.39 USD | |
| 01 Mar 2025 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 9,392 | 0.00 USD | |
| 03 Mar 2025 | SALE | Ultragenyx Pharmaceutical Inc. | 967 | 42.10 USD | |
| 03 Mar 2025 | TAX_WITHHOLDING | Ultragenyx Pharmaceutical Inc. | 141 | 42.92 USD | |
| 01 Mar 2025 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 5,632 | 0.00 USD | deriv |
| 10 Dec 2024 | GIFT | Ultragenyx Pharmaceutical Inc. | 648 | 0.00 USD | |
| 16 Sept 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 700 | 0.00 USD | |
| 03 Sept 2024 | SALE | Ultragenyx Pharmaceutical Inc. | 91 | 56.19 USD | |
| 16 Apr 2024 | TAX_WITHHOLDING | Ultragenyx Pharmaceutical Inc. | 14 | 42.31 USD | |
| 01 Mar 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 13,950 | 0.00 USD | |
| 01 Mar 2024 | TAX_WITHHOLDING | Ultragenyx Pharmaceutical Inc. | 121 | 53.69 USD | |
| 01 Mar 2024 | SALE | Ultragenyx Pharmaceutical Inc. | 341 | 53.76 USD | |
| 01 Mar 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 8,200 | 0.00 USD | deriv |
| 01 Mar 2024 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 2,351 | 0.00 USD | deriv |
| 02 Jan 2024 | EXERCISE | Ultragenyx Pharmaceutical Inc. | 3,000 | 21.00 USD | |
| 20 Dec 2023 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 1,000 | 0.00 USD | |
| 02 Jan 2024 | EXERCISE | Ultragenyx Pharmaceutical Inc. | 3,000 | 0.00 USD | deriv |
| 27 Sept 2023 | GRANT_AWARD | Ultragenyx Pharmaceutical Inc. | 2,351 | 0.00 USD | deriv |
| 07 Sept 2023 | EXERCISE | Ultragenyx Pharmaceutical Inc. | 2,000 | 21.00 USD | |
| 07 Sept 2023 | SALE | Ultragenyx Pharmaceutical Inc. | 2,000 | 41.00 USD | |
| 07 Sept 2023 | SALE | Ultragenyx Pharmaceutical Inc. | 163 | 38.34 USD |